Affiliation:
1. University of Texas Health Science Center, USA
Abstract
Botulinum toxins (BTX) have revolutionised the management of focal post-stroke spastic hypertonia. Published literature has supported the efficacy and safety of BTX in reducing spastic hypertonia but has not convincingly demonstrated the ability to enhance function. While clinicians and stroke survivors have reported impressive clinical outcomes, randomised, con-trolled trials (RCTs), have demonstrated only significant improvement in muscle tone but not functional changes. This paper will review the evidence supporting the efficacy of BTX for spastic hypertonia and discuss current clinical practice.
Key words: Botulinum toxins, Cerebrovascular accident, Spasticity, Stroke
Publisher
Academy of Medicine, Singapore
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Of Rehabilitation Medicine and the Rehabilitation Physician;Annals of the Academy of Medicine, Singapore;2007-01-15